Steven Cohen’s ADMA Biologics ADMA Stock Holding History
Bought
Maintained
Sold
Other funds holding ADMA
Steven Cohen's ADMA Position: Q3 2026 in Review
Steven Cohen reduced its ADMA Biologics (ADMA) stake by 76% in Q3 2026, selling an estimated $2.92M and leaving 98,197 shares worth $985K. The position accounts for ﹤0.01% of the portfolio, ranked #2795.
Steven Cohen first reported a position in ADMA in Q1 2020 and has held it in 13 quarters since. The position peaked at $29.6M in Q1 2026. 330 funds tracked by Wall St. Rank hold ADMA as of Q3 2026.
- Steven Cohen held 98,197 shares of ADMA Biologics worth $985K as of Q3 2026.
- Steven Cohen sold 315,738 ADMA Biologics shares in Q3 2026, an estimated $2.92M.
- ADMA Biologics made up ﹤0.01% of Steven Cohen's portfolio in Q3 2026, its #2795 holding.
- Steven Cohen first reported a position in ADMA Biologics in Q1 2020 and has held it in 13 quarters since.
- Steven Cohen's ADMA Biologics position peaked at $29.6M in Q1 2026.
- 330 funds tracked by Wall St. Rank held ADMA Biologics as of Q3 2026.
Based on Point72 Asset Management's 13F filing for Q3 2026, filed 16 Nov 2026.